Head to Head Survey: Landauer (LDR) & InspireMD (NSPR)
Landauer (NYSE: LDR) and InspireMD (NASDAQ:NSPR) are both small-cap industrial products companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, institutional ownership, dividends and earnings.
This is a breakdown of recent ratings and recommmendations for Landauer and InspireMD, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Landauer presently has a consensus target price of $52.00, indicating a potential downside of 15.72%. Given Landauer’s higher probable upside, research analysts plainly believe Landauer is more favorable than InspireMD.
Landauer pays an annual dividend of $1.10 per share and has a dividend yield of 1.8%. InspireMD does not pay a dividend. Landauer pays out 57.0% of its earnings in the form of a dividend.
Institutional & Insider Ownership
81.4% of Landauer shares are owned by institutional investors. 6.6% of Landauer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Landauer and InspireMD’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Landauer||$153.35 million||3.88||$39.95 million||$1.93||31.97|
|InspireMD||$2.00 million||1.49||-$8.37 million||N/A||N/A|
Landauer has higher revenue and earnings than InspireMD.
This table compares Landauer and InspireMD’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Landauer beats InspireMD on 10 of the 11 factors compared between the two stocks.
Landauer Company Profile
Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company’s Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company’s Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.
InspireMD Company Profile
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.